Table 4.
MSS/MSI-L (n = 62) | MSI-H (n = 47) | Overall HR (95% CI) | |
---|---|---|---|
CD3+ IELs (mean-SD) | |||
Below median (0.03–0.008) | 1# | 0.22 (0.08–0.65) | 1# |
Above median (0.07–0.04) | 0.32 (0.13–0.79) | 0.13 (0.04–0.45) | 0.40 (0.19–0.85) |
CD8+ IELs (mean-SD) | |||
Below median (0.02–0.007) | 1# | 0.34 (0.12–0.90) | 1# |
Above median (0.06–0.04) | 0.38 (0.16–0.94) | 0.09 (0.02–0.39) | 0.33 (0.15–0.73) |
GrB+ IELs (mean-SD) | |||
Below median (0.007–0.004) | 1# | 0.82 (0.33–2.05) | 1# |
Above median (0.02–0.007) | 0.48 (0.19–1.18) | 0.09 (0.02–0.35) | 0.23 (0.10–0.50) |
Overall HR (95% CI) | 1# | 0.31 (0.14–0.68) |
#, Reference category.
In each cell we reported HR (95% CI) from separate models including terms for age, sex, and stage.